Literature DB >> 19249188

Rigid sigmoidoscopy and MRI are not interchangeable in determining the position of rectal cancers.

G Baatrup1, M Bolstad, J H Mortensen.   

Abstract

PURPOSE: 1) To analyse for interchangeability of rigid sigmoidoscopy and MRI in determining the distance from anus to tumour, and to determine if anterior/posterior location influences this difference. 2) To analyse the effect of preoperative chemo-radiotherapy on the distance from anus to tumour.
METHODS: Retrospective investigation of endoscopy reports and MRI series of 144 consecutive patients operated for rectal cancer.
RESULTS: The mean distance from the anal verge to the tumour measured by sigmoidoscopy was 82mm and by MRI 61mm (p<0.01). For tumours in the anterior quadrant this difference was 30mm and for tumours located in the posterior quadrant only 12mm. The distributions of the cancers as low, middle and high differ by more than 10% between the two methods. The coefficient of correlation between measurements was 0.9 but the variation was not acceptable. The length of the tumours decreased by 16mm after neoadjuvant treatment, but the distance from tumour to anus increased by only 4mm.
CONCLUSION: 1) MRI and sigmoidoscopy are not interchangeable in determining the distance from anus to tumour simply by correcting for the length of the anal canal. It has not been determined if measurements from MRI or sigmoidoscopy are more accurate, but current evidence concerning the effect of neoadjuvant irradiation at different positions in the rectum is based upon rigid sigmoidoscopy. 2) The gain in tumour free distance above the anus induced by neoadjuvant treatment is small. Facilitation of sphincter-saving surgery should not be an argument for neoadjuvant treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19249188     DOI: 10.1016/j.ejso.2009.02.004

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  A comparison of the localization of rectal carcinomas according to the general rules of the Japanese classification of colorectal carcinoma (JCCRC) and Western guidelines.

Authors:  Akira Tanaka; Sotaro Sadahiro; Toshiyuki Suzuki; Kazutake Okada; Gota Saito
Journal:  Surg Today       Date:  2017-03-07       Impact factor: 2.549

Review 2.  Magnetic resonance imaging in rectal cancer: a surgeon's perspective.

Authors:  Avanish P Saklani; Sung Uk Bae; Amy Clayton; Nam Kyu Kim
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

3.  Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40/87.

Authors:  S A Käser; J Froelicher; Q Li; S Müller; U Metzger; M Castiglione; U T Laffer; C A Maurer
Journal:  Langenbecks Arch Surg       Date:  2014-08-28       Impact factor: 3.445

4.  Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference.

Authors:  Mario Morino; Mauro Risio; Simon Bach; Regina Beets-Tan; Krzysztof Bujko; Yves Panis; Philip Quirke; Bjorn Rembacken; Eric Rullier; Yutaka Saito; Tonia Young-Fadok; Marco Ettore Allaix
Journal:  Surg Endosc       Date:  2015-01-22       Impact factor: 4.584

5.  Comparison of MRI and colonoscopy in determining tumor height in rectal cancer.

Authors:  Lotte Jacobs; David B Meek; Joost van Heukelom; Thomas L Bollen; Peter D Siersema; Anke B Smits; Ellen Tromp; Maartje Los; Bas Lam Weusten; Niels van Lelyveld
Journal:  United European Gastroenterol J       Date:  2017-04-21       Impact factor: 4.623

6.  Which Definition of Upper Rectal Cancer Is Optimal in Selecting Stage II or III Rectal Cancer Patients to Avoid Postoperative Adjuvant Radiation?

Authors:  Xian Hua Gao; Bai Zhi Zhai; Juan Li; Jean Luc Tshibangu Kabemba; Hai Feng Gong; Chen Guang Bai; Ming Lu Liu; Shao Ting Zhang; Fu Shen; Lian Jie Liu; Wei Zhang
Journal:  Front Oncol       Date:  2021-02-12       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.